Division of Hepatology, Miami VA Medical Center, Miami, FL.
Division of Hospital Medicine, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
Transplantation. 2022 Jan 1;106(1):72-84. doi: 10.1097/TP.0000000000003615.
Successful liver transplantation offers the possibility of improved survival among patients with decompensated cirrhosis. However, there is wide variability in access to care and promptness of the transplant evaluation process in the United States.
We performed a multicenter retrospective study of 1118 patients who underwent evaluation for liver transplantation at the 6 Veterans Affairs' transplant centers from 2013 to 2018. Of these, 832 patients were evaluated within 30 d and 286 > 30 d after referral. We studied the differential effects of the time from referral to evaluation on pretransplant and posttransplant mortality and transplant list dropout and explored predictors of early transplant evaluation.
Patients in the early evaluation group had a shorter adjusted time from referral to listing by 29.5 d (95% confidence interval [CI] -50.4, -8.5, P < 0.006), and referral to transplantation by 115.1 d (95% CI -179.5, -50.7, P < 0.0001). On a multivariable Cox hazard model, evaluation within 30 d of referral was associated with a significantly lower pretransplant mortality (adjusted hazard ratio [aHR] 0.70, 95% CI 0.54-0.91, P < 0.01), but not associated with transplant list dropout (aHR 0.95, 95% CI 0.65-1.39, P = 0.79) or posttransplant death (aHR 1.88, 95% CI 0.72-4.9, P = 0.20). An early evaluation within 30 d was positively associated with a higher MELD at referral (aHR 1.03, 95% CI 1.01-1.06, P = 0.006) and negatively associated with distance from the transplant center (aHR 0.99, 95% CI 0.99-0.99, P = 0.045).
Evaluation of patients referred for liver transplantation within 30 d is associated with a reduction in pretransplant mortality.
成功的肝移植为失代偿性肝硬化患者提供了提高生存率的可能性。然而,在美国,获得护理的机会和移植评估过程的及时性存在很大差异。
我们对 2013 年至 2018 年间在 6 个退伍军人事务部移植中心接受肝移植评估的 1118 名患者进行了一项多中心回顾性研究。其中,832 名患者在转诊后 30 天内进行了评估,286 名患者>30 天进行了评估。我们研究了从转诊到评估的时间对移植前和移植后死亡率以及移植名单脱落的差异影响,并探讨了早期移植评估的预测因素。
早期评估组患者从转诊到列入名单的调整时间缩短了 29.5 天(95%置信区间[CI] -50.4,-8.5,P <0.006),从转诊到移植的时间缩短了 115.1 天(95% CI -179.5,-50.7,P <0.0001)。在多变量 Cox 风险模型中,30 天内评估与移植前死亡率显著降低相关(调整后的危险比[aHR] 0.70,95% CI 0.54-0.91,P <0.01),但与移植名单脱落无关(aHR 0.95,95% CI 0.65-1.39,P =0.79)或移植后死亡(aHR 1.88,95% CI 0.72-4.9,P =0.20)。30 天内的早期评估与转诊时更高的 MELD 评分呈正相关(aHR 1.03,95% CI 1.01-1.06,P =0.006),与离移植中心的距离呈负相关(aHR 0.99,95% CI 0.99-0.99,P =0.045)。
在 30 天内对接受肝移植评估的患者进行评估与降低移植前死亡率相关。